Kahma Biotech

Kahma Biotech. A Kahma Group Division.

About Kahma Biotech

The founders of the Kahma Healthcare Group established The Biovac Institute – the only local human vaccines manufacturing entity in partnership with the South African government.

Since its inception Biovac has grown from strength-to-strength and today is an independent company controlled and owned by Kahma’s empowerment partners.

Kahma Biotech enjoys a strategic and synergistic relationship with Biovac, where Kahma focuses mainly on the commercialisation of biotech products including vaccines targeted at adults whilst Biovac is a specialist vaccine manufacturing company.

Professional Information Leaflets

Casfin
50mg and 70mg

Dapicub
500mg

Micononin
50mg and 100mg

Nivazen
1mg

Chirorab
1ml

Tuberculin
0.1ml
Heberprot-P
75µg
VesiCulture
30mg

Urilosin
0.4mg

Clozurb
10mg and 2mg

Drug Safety

For safety issues/adverse event or a complaint around a product, please report it to us using pv@kahmagroup.co.za